Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joanne M. Smallheer is active.

Publication


Featured researches published by Joanne M. Smallheer.


Journal of Medicinal Chemistry | 2014

Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors.

Mimi L. Quan; Pancras C. Wong; Cailan Wang; Francis J. Woerner; Joanne M. Smallheer; Frank A. Barbera; Jeffrey M. Bozarth; Randi L. Brown; Mark R. Harpel; Joseph M. Luettgen; Paul E. Morin; Tara L. Peterson; Vidhyashankar Ramamurthy; Alan R. Rendina; Karen A. Rossi; Carol A. Watson; Anzhi Wei; Ge Zhang; Dietmar A. Seiffert; Ruth R. Wexler

Antithrombotic agents that are inhibitors of factor XIa (FXIa) have the potential to demonstrate robust efficacy with a low bleeding risk profile. Herein, we describe a series of tetrahydroquinoline (THQ) derivatives as FXIa inhibitors. Compound 1 was identified as a potent and selective tool compound for proof of concept studies. It exhibited excellent antithrombotic efficacy in rabbit thrombosis models and did not prolong bleeding times. This demonstrates proof of concept for the FXIa mechanism in animal models with a reversible, small molecule inhibitor.


Journal of Medicinal Chemistry | 2014

Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity

Jon J. Hangeland; Todd J. Friends; Karen A. Rossi; Joanne M. Smallheer; Cailan Wang; Zhong Sun; James R. Corte; Tianan Fang; Pancras C. Wong; Alan R. Rendina; Frank A. Barbera; Jeffrey M. Bozarth; Joseph M. Luettgen; Carol A. Watson; Ge Zhang; Anzhi Wei; Vidhyashankar Ramamurthy; Paul E. Morin; Gregory S. Bisacchi; Srinath Subramaniam; Piramanayagam Arunachalam; Arvind Mathur; Dietmar A. Seiffert; Ruth R. Wexler; Mimi L. Quan

Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) having in vivo antithrombotic efficacy in the rabbit AV-shunt thrombosis model (ID50 = 0.6 mg/kg + 1 mg kg(-1) h(-1)). Initial analog selection was informed by molecular modeling using compounds 11a and 11h overlaid onto the X-ray crystal structure of tetrahydroquinoline 3 complexed to FXIa. Further optimization was achieved by specific modifications derived from careful analysis of the X-ray crystal structure of the FXIa/11h complex. Compound 16b was well tolerated and enabled extensive pharmacologic evaluation of the FXIa mechanism up to the ID90 for thrombus inhibition.


Tetrahedron Letters | 1992

Synthesis of 1,5-dimethyl-1,4-dihydropyrrolo[3,4-b]-pyrrol-6(5H)-one by intramolecular Diels-Alder reaction to the imidazole nucleus.

Mark A. Wuonola; Joanne M. Smallheer

Abstract N-Methyl-N-propargylimidazole-5-carboxamide undergoes thermal intramolecular Diels-Alder reaction to give the title compound. A related reaction of the corresponding sydnone system is also described.


Tetrahedron Letters | 1991

Intramolecular diels-alder reactions of isoquinoline-1-carboxamides

Mark A. Wuonola; Joanne M. Smallheer; J.M. Read; Joseph C. Calabrese

Abstract N -methyl- N -propargyl and N -methyl- N -allylisoquinoline-1-carboxamides undergo facile intramolecular Diels-Alder reactions to give fused N -methyl-γ-lactams.


Journal of Medicinal Chemistry | 2010

Factor Xa Inhibitors: Next-Generation Antithrombotic Agents

Donald J. P. Pinto; Joanne M. Smallheer; Daniel L. Cheney; Robert M. Knabb; Ruth R. Wexler


Proceedings of the National Academy of Sciences of the United States of America | 2000

A nonpetide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin α5β1-fibronectin-M1 protein complexes

David Cue; Sarka O. Southern; Peter J. Southern; Jadhar Prabhakar; William Lorelli; Joanne M. Smallheer; Shaker A. Mousa; P. Patrick Cleary


Journal of Medicinal Chemistry | 2000

Isoxazolines as Potent Antagonists of the Integrin αvβ3

William J. Pitts; John Wityak; Joanne M. Smallheer; A. Ewa Tobin; James W. Jetter; Jennifer S. Buynitsky; Patricia P. Harlow; Kimberly A. Solomon; Martha H. Corjay; Shaker A. Mousa; and Ruth R. Wexler; Prabhakar K. Jadhav


Archive | 2001

Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors

Irina C. Jacobson; Ruth R. Wexler; Suanne Nakajima; Mimi L. Quan; Shuaige Wang; Joanne M. Smallheer; Jennifer X. Qiao


Archive | 2004

Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors

Joanne M. Smallheer; Mimi L. Quan; Shuaige Wang; Gregory S. Bisacchi


Archive | 1996

Isoxazoline and isoxazole derivatives as integrin receptor antagonists

Matthew E. Voss; Prabhakar K. Jadhav; Joanne M. Smallheer; Douglas G. Batt; William J. Pitts; John Wityak

Collaboration


Dive into the Joanne M. Smallheer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge